Quick Answer
Bone Biologics Corp reported Research And Development Expense of $1.06 million for the year ending 2025.
- Bone Biologics Corp showed a decrease of -50.2% in Research And Development Expense from 2024 to 2025.
- This data is from Bone Biologics Corp's annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Bone Biologics Corp's Research And Development Expense has grown by 463.2%.
- Historical annual values: Fiscal year 2025: $1.06 million | Fiscal year 2024: $2.13 million | Fiscal year 2023: $6.91 million | Fiscal year 2022: $1.58 million | Fiscal year 2021: $82.0 thousand | Fiscal year 2020: $340.7 thousand | Fiscal year 2019: $1.10 million | Fiscal year 2018: $104.5 thousand | Fiscal year 2017: $1.42 million | Fiscal year 2016: $10.17 million | Fiscal year 2015: $3.67 million | Fiscal year 2014: $623.5 thousand | Fiscal year 2013: $188.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: